ARROWHEAD PHARMACEUTICALS, INC. — Director's Dealing 2025

Feb 7, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
CIK: 0000879407
Period of Report: 2025-02-06

Reporting Person: INGRAM DOUGLAS S (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-02-06	Common Stock	A	38396	$20.09	Acquired	38396	Direct

Footnotes

F1: Represents shares underlying restricted stock units with a grant date 02/06/2025, which will vest in three years.